针对不可用药物 - - 蛋白质降解剂的力量
Chao Zhang1, Yongbo Liu2, Guangchen Li2
1Changping Laboratory, Beijing 102206, China.
Science bulletin
|April 13, 2024
概括
针对性蛋白质降解技术为以前无法治疗的目标药物开发提供了一种新的方法. 这些方法利用细胞通路来降解引起疾病的蛋白质,克服传统治疗的局限性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 超过80%的与疾病相关的蛋白质被认为是传统方法无法治疗的.
- 具有挑战性的药物标具有重要的临床意义,但缺乏有效的治疗策略.
- 基础研究和技术的进步对于开发新的治疗方法至关重要.
研究的目的:
- 系统地审查针对性蛋白质降解技术的应用,以应对具有挑战性的药物目标.
- 探索超越传统方法的新药开发策略.
- 为了提供对目标蛋白质降解的未来的见解.
主要方法:
- 针对性蛋白质降解技术的审查,包括PROTAC,分子,LYTAC,ATTEC,AUTAC,AUTOTAC和DAC.
- 分析这些技术降解目标蛋白质的机制.
- 对这些降解剂在具有挑战性的目标中的应用进行当前研究的综合.
主要成果:
- 有针对性的蛋白质降解利用细胞机械选择性地降解病原蛋白质.
- 像PROTAC和分子等各种技术代表了药物开发的突破.
- 这些方法为以前无法治疗的目标提供了可行的策略.
结论:
- 有针对性的蛋白质降解是开发针对具有挑战性的疾病点的治疗方法的一个有希望的策略.
- 多样化的技术范围在药物发现中提供了灵活性和广泛的应用.
- 未来的研究方向和应用前景对这一领域具有重要意义.
相关概念视频
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
The Proteasome Structure
748
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
748


